UBS ASSET MANAGEMENT AMERICAS LLC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$488,400,000
+20.0%
27,500
-6.8%
0.00%
Q2 2018$407,100,000
+262545.2%
29,500
-13.0%
0.00%
Q3 2015$155,000
-11.9%
33,8990.0%0.00%
Q2 2015$176,000
-17.0%
33,8990.0%0.00%
Q1 2015$212,000
-0.5%
33,8990.0%0.00%
Q4 2014$213,000
-97.9%
33,899
-92.2%
0.00%
-100.0%
Q1 2014$10,359,000
+70.9%
435,060
-23.3%
0.01%
+57.1%
Q4 2013$6,062,000567,0600.01%
Other shareholders
ENDOCYTE INC shareholders Q2 2018
NameSharesValueWeighting ↓
RA Capital Management 3,364,648$14,401,0001.20%
Asymmetry Capital Management, L.P. 81,484$349,0000.47%
PFM Health Sciences, LP 3,441,594$14,730,0000.35%
Perceptive Advisors 1,451,700$6,213,0000.21%
Leisure Capital Management 28,304$121,0000.10%
Cribstone Capital Management, LLC 47,349$203,0000.10%
EAM Investors, LLC 98,034$420,0000.08%
SG3 Management, LLC 32,500$139,0000.05%
Baker Brothers Advisors 1,087,323$4,654,0000.04%
Alpine Global Management, LLC 33,675$144,0000.03%
View complete list of ENDOCYTE INC shareholders